title: Panfacial botulinum toxin improves patient retention.
abstract: The injection of botulinum toxin (Botox, Allergan, Irvine, CA) is the most common cosmetic procedure in the U.S. In the past 5 years, its use has climbed over 388%. In 2005, business development managers from Allergan audited 1695 patient charts from the top 54 cosmetic practices in Canada. Despite the increasing popularity of this nonsurgical treatment, on average only 57% of patients return for a second injection within 6 months. In the author's clinical practice 92% of patients return for a second injection in this time frame. This paper will examine various factors that appear to result in satisfied patients with a high retention rate. This article will show that panfacial botulinum toxin injected in multiple sites with appropriate dosing improves patient retention.
authors: Vancouver Laser and Skin Care Center, Vancouver, BC, Canada. info@vancouverlaser.com
authors: Martin
authors: M
authors: Braun
mesh_terms: D000328:Adult; D017677:Age Distribution; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002170:Canada; D003357:Cosmetic Techniques / Q000592:standards* / Q000639:trends; D005145:Face; D005152:Facial Muscles / Q000187:drug effects; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008722:Methods; D008875:Middle Aged; D010342:Patient Acceptance of Health Care; D017060:Patient Satisfaction / Q000706:statistics & numerical data*
chemical_list: D019274:Botulinum Toxins, Type A